Aromatase inhibitors adjuvant therapy postmenopausal hormone recept-pos early breast cancer

Supporting evidence for the national breast cancer centre hormonal therapies guidelines working group. 45 page document.

Back to search Download PDF

File name:	htrw-aromatase-inhibitors-a...st-cancer_504af032a1c8b.pdf
File size:	441.54 KB
Cancer Type:	Breast cancer
Publication Audience:	Resources for health professionals
Year:	2006
Document Status:	Greater than 5 years This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Cancer Australia Publications